U.S. and Iranian teams are set to hold "technical-level" talks, according to Pakistan's foreign ministry. But fighting in ...
PCWorld demonstrates how Windows 11 users can run classic PC games from the 80s and 90s using DOSBox, a free emulator that simulates MS-DOS environments. DOSBox supports vintage titles like ...
A Des Moines running club is being required by the city to pay over $4,300 in permit fees to use a public park. The 515 Run Club, which is free and informal, argues the fees are unjust as they use ...
What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...
Valve already collects a lot of data about your gaming PC, typically to release its hardware survey every month. But it looks like Steam will soon use frame rate data gathered by its millions of users ...
The Seattle Times’ Education Lab examines the educational system from early childhood through post-secondary. Education Lab is supported by Gates Foundation, Ballmer Group and The Norcliffe Foundation ...
AI expert Allie K. Miller demonstrates Anthropic's Claude Cowork, an AI agent tool that automates extensive business tasks. It analyzes documents, conducts research, builds interactive dashboards, and ...
I can't stand opening the Microsoft Store. It's slow to load, confusing to browse, and full of ads for things I don't care about. Luckily, thanks to a new feature, I don't have to open the Microsoft ...
Federal Communications Commission Chair Brendan Carr is urging broadcast media companies to air “patriotic, pro-America content” in a new campaign aligned with President Donald Trump’s Freedom 250 ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Amgen’s decision to terminate its rocatinlimab collaboration with Kyowa Kirin follows the publication of data on Sanofi’s rival OX40 drug candidate amlitelimab. (iStock / Getty Images Plus) Amgen has ...